Evidence map›Paper›PMID 35694361›Full record

ArticleChemical science2022

Development of 1,3-acetonedicarboxylate-derived glucoside amphiphiles (ACAs) for membrane protein study.

Ho Jin Lee, Muhammad Ehsan, Xiang Zhang, Satoshi Katsube, Chastine F Munk, Haoqing Wang, Waqar Ahmed, Ashwani Kumar, Bernadette Byrne, Claus J Loland and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Ho Jin LeeDepartment of Bionano Engineering, Hanyang University Ansan 155-88 Korea pchae@hanyang.ac.kr.ORCID https://orcid.org/0000-0002-0177-0061
Muhammad EhsanDepartment of Bionano Engineering, Hanyang University Ansan 155-88 Korea pchae@hanyang.ac.kr.
Xiang ZhangBeijing Advanced Innovation Center for Structural Biology, School of Medicine, School of Pharmaceutical Sciences, Tsinghua University 100084 Beijing China.
Satoshi KatsubeDepartment of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center Lubbock TX 79430 USA.ORCID https://orcid.org/0000-0002-3312-7476
Chastine F MunkDepartment of Neuroscience, University of Copenhagen Copenhagen DK-2200 Denmark.
Haoqing WangDepartment of Molecular and Cellular Physiology, Stanford University California 94305 USA.
Waqar AhmedDepartment of Bionano Engineering, Hanyang University Ansan 155-88 Korea pchae@hanyang.ac.kr.
Ashwani KumarDepartment of Bionano Engineering, Hanyang University Ansan 155-88 Korea pchae@hanyang.ac.kr.ORCID https://orcid.org/0000-0002-5375-8136
Bernadette ByrneDepartment of Life Sciences, Imperial College London London SW7 2AZ UK.ORCID https://orcid.org/0000-0001-9598-9832
Claus J LolandDepartment of Neuroscience, University of Copenhagen Copenhagen DK-2200 Denmark.ORCID https://orcid.org/0000-0002-1773-1446
Lan GuanDepartment of Cell Physiology and Molecular Biophysics, Center for Membrane Protein Research, School of Medicine, Texas Tech University Health Sciences Center Lubbock TX 79430 USA.
Xiangyu LiuBeijing Advanced Innovation Center for Structural Biology, School of Medicine, School of Pharmaceutical Sciences, Tsinghua University 100084 Beijing China.
Pil Seok ChaeDepartment of Bionano Engineering, Hanyang University Ansan 155-88 Korea pchae@hanyang.ac.kr.ORCID https://orcid.org/0000-0003-1799-3304
Hanyang University · KRBeijing Advanced Sciences and Innovation Center · CNTexas Tech University · USUniversity of Copenhagen · DKImperial College London · GBStanford University · US

Funding

Integrated approaches to symport mechanisms of membrane transportersR01GM122759 · NIGMS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GUAN, LAN · 2018 to 2021
$1.4M
Recombinant expression and functional characterization of a lysophosphatidylcholine transporterR21NS105863 · NINDS · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GUAN, LAN · 2018 to 2019
$421k
NIGMS NIH HHS R01 GM122759NINDS NIH HHS R21 NS105863
6 · The paper itself

Abstract

Detergents are extensively used for membrane protein manipulation. Membrane proteins solubilized in conventional detergents are prone to denaturation and aggregation, rendering downstream characterization of these bio-macromolecules difficult. Although many amphiphiles have been developed to overcome the limited efficacy of conventional detergents for protein stabilization, only a handful of novel detergents have so far proved useful for membrane protein structural studies. Here, we introduce 1,3-acetonedicarboxylate-derived amphiphiles (ACAs) containing three glucose units and two alkyl chains as head and tail groups, respectively. The ACAs incorporate two different patterns of alkyl chain attachment to the core detergent unit, generating two sets of amphiphiles: ACA-As (asymmetrically alkylated) and ACA-Ss (symmetrically alkylated). The difference in the attachment pattern of the detergent alkyl chains resulted in minor variation in detergent properties such as micelle size, critical micelle concentration, and detergent behaviors toward membrane protein extraction and stabilization. In contrast, the impact of the detergent alkyl chain length on protein stability was marked. The two C11 variants (ACA-AC11 and ACA-SC11) were most effective at stabilizing the tested membrane proteins. The current study not only introduces new glucosides as tools for membrane protein study, but also provides detergent structure-property relationships important for future design of novel amphiphiles.

Identifiers

PMID35694361
PMCPMC9116450
OpenAlexW4226077726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.